News & Media

February 14, 2023
Entrinsic Bioscience® Expands enterade® Brand with Innovative Approach to the Dietary Support of Irritable Bowel Syndrome with Diarrhea (IBS-D)

April 12, 2022
Entrinsic Bioscience Announces Tool with Potential for Development of New Therapies Addressing Constipation

April 12,2022
Entrinsic Bioscience Steps Closer to Amino Acid Formulation as Therapy for Cystic Fibrosis

February 22, 2022
Entrinsic Bioscience Announces Successful European Patent Defense

January 19, 2022
Entrinsic Bioscience Demonstrates Breakthrough GI Barrier Benefits

April 28, 2021
Internationally Renowned Skin Expert Dr. Apostolos Pappas Joins entrinsic bioscience as Senior Dermatology Consultant; Accelerates Work to Deliver World’s First Natural Anti-Wrinkle Formula With Equal to or Greater Efficacy Than Chemical Based Market Leaders

April 15, 2021
Entrinsic Biosciences’ First Commercial Product (enterade® Advanced Oncology Formula) Delivers a Potentially Life Saving Alternative to Cancer Patients Considering Discontinuing Therapy Because of the Debilitating Side Effects

April 5, 2023
Patients Attest to the Efficacy of EBS’s First Commercial Product – enterade Advanced Oncology Formula, Clinically Proven to Reduce the Side Effects of Cancer Treatment

March 22, 2023
World Class Partners, Positive Clinical Study Results, and Successful Uptake of Breakthrough Oncology Product Demonstrate Strong Proof of Concept for entrinsic bioscience’s Protein Modulation Platform

March 11, 2021
entrinsic Bioscience novel biocatalyst platform a potential game changer to address inflammatory bowel disease (IBD) that continues to affect a substantial proportion of the US adult and pediatric population

March 4, 2021
entrinsic Bioscience poised to deliver breakthroughs to treat the more than 25% of adults suffering from quality of life limiting functional bowel disorders (FBDs), including IBS, IBS-C, IBS-D, functional constipation, functional diarrhea, and opioid-induced constipation

October 15, 2020
entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program

September 29, 2020
entrinsic bioscience Puts Its Rapid Hydration Breakthrough to the Test at World’s Leading University for Exercise Science

September 23, 2020
Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida’s “Invention of the Year 2020” Award

September 14, 2020
entrinsic bioscience Expands GI Health Program with Appointment of Renowned Barrier Function Expert Dr. Jerrold Turner as New Scientific Advisor

September 8, 2020
entrinsic bioscience Strengthens Leadership Team with Appointment of Mario Wanderley as Chief Financial Officer and Accelerates Product Development with New Research Facility

August 21, 2020
entrinsic bioscience congratulates Chief Science Officer and company co-founder, Dr. Sadasivan Vidyasagar, on his tenure appointment at the University of Florida.

December 12, 2018
Entrinsic Health Solutions and Markey Cancer Center Launch Phase II Study for Neuroendocrine Tumor Patients with Quality of Life-Limiting Diarrhea

November 20, 2018
UF Innovate | Tech Licensing Announces Another Successful Partnership with Portfolio Company Entrinsic Health Solutions Inc.

May 21, 2018
Entrinsic Health Solutions & Markey Cancer Center Announce Publication of Neuroendocrine Tumor Clinical Data in 2018 ASCO Annual Meeting Proceedings

April 30, 2018
Entrinsic Health Solutions and Brigham & Women’s Hospital Launch Pilot Study in Patients with Inflammatory Bowel Disease

April 18, 2018
Entrinsic Health Solutions Publishes Clinical Study Showing Amino Acid-Based Solution Has Greater Hydration Index Value Compared to Water & Sports Drink

March 14, 2018
Entrinsic Health Solutions Announce Journal of Parental & Enteral Nutrition Publication of Clinical Data Comparing Efficacy of Rehydration Therapies

February 28, 2018
Entrinsic Health Solutions and Markey Cancer Center Present Clinical Data in Patients with Neuroendocrine Tumors

January 19, 2018
Gastrointestinal Cancers Symposium Poster Presentation

June 23, 2017
Entrinsic Health Solutions Announces Data from Poster Presentation at ISSN Annual Meeting

June 22, 2017
Entrinsic Health Solutions Announces Data from Poster Presentation at MASCC Annual Meeting

May 10, 2017
Read Dr. Okunieff & Dr. Vidyasagar’s latest publication entitled ‘Glucose enhances rotavirus enterotoxin-induced intestinal chloride secretion

May 6, 2017
An Amino Acid Based Oral Rehydration Solution Increased Zinc Absorption In Mice Exposed to Radiation

April 27, 2017
Entrinsic Health Solutions Announces Positive Top Line Clinical Trial Results in Retrospective Study of enterade

December 6, 2016
Researchers learn more about drink that aids post-radiation recovery

November 29, 2016
Scientific advancement in Supportive Care for Cancer Patients published in Nature Scientific Reports

July 20, 2016
EHS to attend 11th Annual New Orleans Summer Cancer Meeting

June 01, 2016
Preliminary Characterization of Enterade® Rehydration Kinetics Following Intra- and Extracellular Dehydration

June 01, 2016
Entrinsic Health Solutions Announces Data from Poster Presentation at ACSM Annual Meeting

May 17, 2016
Space Institute to Fund Testing of Radiation Protectants

May 17, 2016
Addressing Radiation: Watch the video highlighting the work of the BioShield 4 Mars grant recipients

June 15, 2015
Entrinsic Health Announces Issuance of U.S Patent for Its Glucose-Free, Amino Acid Formulation for Maintaining Gastrointestinal Health

June 1, 2015
World Health Organization’s Medical Officer in the Diarrheal Diseases Control Programme, Olivier Fontaine, M.D., Joins Entrinsic Health Solutions’ Scientific Advisory Board